Yvonne Award 2025
The Yvonne Award, symbolizing the strength and longevity of the yew tree, honors exceptional achievements in oncology with its unique Y-shaped sculpture that embodies resilience. Designed to recognize young innovators and leaders advancing cancer care, this award celebrates excellence and innovation in the field.
Yvonne Award will be given during the OncoDaily Party 2025 on May 30th.
Eligibility and Nomination Requirements
- Candidates must be within 10 years post-faculty appointment or after receiving their terminal degree.
- Both trainees and seasoned professionals are eligible to be nominated.
- It is mandatory for the awardee to attend the ASCO Annual Meeting and Yvonne Award Ceremony on May 30th in person
- Nominations should include a CV (limited to 2 pages)
Yvonne Award Categories
- Breakthrough Research
- Global Oncology
- Community Oncology
- Leadership
- Mentorship
- Challenging the Status Quo
- Pediatric Oncology
- Humanitarian Award
The deadline for the nominations is May 10, 2025.
Please, submit your nominations for the Yvonne Award through the following link.
Yvonne Award Nomination Committee
2025 Co-chairs
Lynn Schuchter (USA): ASCO Board Chair and Past-President, Chief of the Division of Hematology-Oncology at the Abramson Cancer Center at the University of Pennsylvania and the Director of the Tara Miller Melanoma Center, Professor of Clinical Oncology, the Madlyn and Leonard Abramson. 2019 the Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award Recipient
Larry Norton (USA): ASCO Past-President, Senior Vice President of the Memorial Sloan Kettering Cancer Center, Medical Director of the Evelyn H. Lauder Breast Center, Norna S. Sarofim Chair in Clinical Oncology, Professor of Medicine, Weill-Cornell Medical College, Founder and Scientific Director of the Breast Cancer Research Foundation, 2004 ASCO David Karnofsky Memorial Award Recipient.
Members
Lillian Siu (Canada) – Co-chair of Yvonne Award 2024: President-Elect of the American Association for Cancer Research (AACR), Director of the Phase I Clinical Trials Program and Co-Director of the Bras and Family Drug Development Program, Clinical Lead for the Tumor Immunotherapy Program, BMO Chair in Precision Genomics at the Princess Margaret Cancer Centre, Professor of Medicine at the University of Toronto, 2024 ASCO David Karnofsky Memorial Award Recipient
Giuseppe Curigliano (Italy) – Co-chair of Yvonne Award 2024: President-Elect of European Society of Medical Oncology (ESMO). Professor of Medical Oncology at the University of Milano, Chief of the Clinical Division of Early Drug Development at European Institute of Oncology, Chair of the ESMO Clinical Practice Guidelines Committee, Member of the Italian Higher Health Council
Abeid Mohamed Athman Omar (Kenya) – Yvonne Award 2024 Recipient, Head of Oncology Department at Kenyatta University Teaching, Referral and Research Hospital
Adriana Albini (Italy) – Co-Editor-in-Chief of CancerWorld Magazine, scientific collaborator at the European Institute of Oncology in Milan and a Professor of General Pathology at Milan Bicocca University
Alberto Costa (Italy) – CEO of the European School of Oncology
Aleksandra Filipovic (UK) – Head of Oncology at PureTech Health, Scientific Clinical Adviser at SPCC
Alique Topalian (USA) – Research Scientist of Survivorship and Supportive Services at University of Cincinnati Cancer Center
Allison Magnuson (USA) – Geriatric Oncologist, Associate Professor at the Department of Medicine, Hematology/Oncology, Director of the Specialized Oncology Care and Research in the Elderly (SOCARE) Clinic, University of Rochester Medical Center
Amy Moore (USA) – Director of Patient Engagement and Advocacy, Summit Therapeutics; Former Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation
Andre Ilbawi (Switzerland) – Technical lead, Cancer Control Department of Noncommunicable Diseases, Rehabilitation and Disability (NCD), World Health Organization
Anna Spreafico (Canada) – Yvonne Award 2024 Recipient, Associate Professor at the University of Toronto, Medical Oncologist and Clinician-Investigator in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre
Armen Avagyan (Armenia) – Medical Oncologist, Department of Oncology at Mikaelyan Institute of Surgery, Assistant Professor of Oncology at Yerevan State Medical University, Past-President of the Armenian Association of Hematology and Oncology
Asya Agulnik (USA) – Yvonne Award 2024 Recipient, Director of Global Critical Care Program and EURO Regional Program at St. Jude Global, St. Jude Children’s Research Hospital
Bishal Gyawali (Canada) – Medical oncologist and associate professor in medical oncology and public health sciences, Queen’s University, Kingston, Co-leader of the Common Sense Oncology movement
Catharine Young (USA) – Former Assistant Director for Policy and International Engagement for the Biden Cancer Moonshot at the White House Office of Science and Technology Policy
Cathy Eng (USA) – David H. Johnson Endowed Chair in Surgical and Medical Oncology, Professor of Medicine, Hematology and Oncology,
Director for Strategic Relations, Co-Director of GI Oncology and Co-Leader, GI Cancer Research Program, Director of Young Adult Cancers Program, Vanderbilt-Ingram Cancer Center, Vice-Chair for the SWOG GI Committee
Daiming Fan (China) – President of China Anti-Cancer Association (CACA), President of World Association for Integrative Oncology (WAIO), President of Asian Oncology Society (AOS), Vice President of Chinese Academy of Engineering, Past President of Fourth Military Medical University, Past President of Chinese Society of Gastroenterology, Director of Xijing Hospital of Digestive Diseases, Director of State Key Laboratory of Cancer Biology
Davit Zohrabyan (Armenia) – Head of the Adult Solid Tumours and Chemotherapy Clinic at Yeolyan Oncology and Hematology Center, ESMO National Representative in Armenia
Dhan Chand (USA) – Vice President of Research, Agenus Inc.
Dickran Kazandjian (USA) -Professor of Medicine at the Sylvester Comprehensive Cancer Center, University of Miami
Dilyara Kaidarova (Kazakhstan) – Chairman of the Board at the Kazakh Institute Of Oncology and Radiology, President of the Kazakhstan Cancer Society
Dinesh Pendharkar (India) – Director of Oncology, Sarvodaya Hospital Faridabad, Chairman of the National Cancer Society, Past-President of the Indian Society of Oncology, Past-President of the Indian Society of Medical & Paediatric Oncology (ISMPO), Past Chair of the ASCO International Committee
Douglas Flora (USA) – Editor in Chief of AI in Precision Oncology, President-Elect of Association of Cancer Care Centers (ACCC), Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, Vice-Chair of the American Cancer Society Regional Board
Eirini Bournazou (USA) – Director, External Opportunity Assessments & Evaluations, Bristol-Myers Squibb
Elen Baloyan (Armenia) – Managing Editor of OncoDaily, Medical Oncologist
Emad Shash (Egypt) –Medical Director & General Manager, Breast Comprehensive Cancer Hospital at the National Cancer Institute, Cairo University
Eric Bouffet (Canada) – Past-President of the International Society of Pediatric Oncology (SIOP), UICC Board Member
Eric Small (USA) – ASCO President – Elect, Co-Leader of the UCSF Prostate Cancer Program and Deputy Director and Chief Scientific Officer at the Helen Diller Family Comprehensive Cancer Center, UCSF
Erica Barnell (USA) – Co-Founder and Chief Medical and Science Officer of Geneoscopy
Erica Tsang (Canada) – Yvonne Award 2024 recipient, Medical oncologist at the Princess Margaret Cancer Centre and an Assistant Professor at the University of Toronto
Foluke Sarimiye (Nigeria) – Community Oncologist at University of Ibadan, Yvonne Award 2024 recipient
Gabrielle van Ramshorst (Belgium) – Professor of Gastrointestinal Surgical Oncology, Ghent University Hospital
George Kapetanakis (Greece) – President of the Hellenic Cancer Federation – ELLOK
Ghassan Abou-Alfa (USA) – Professor of Medicine at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Immediate Past-Chair of the National Cancer Institute (NCI) Hepatobiliary Task Force
Greg Kalemkerian (USA) – Professor of Internal Medicine at the University of Michigan, Associate Division Chief for Faculty Development & Education and Associate Director of the Hem/Onc Fellowship Program, Medical School, Chair of the NCCN Small Cell Lung Cancer Guideline Panel
Guillermo Chantada (Spain) – President of the International Society of Paediatric Oncology (SIOP), Head Outreach Program at the Hospital Sant Joan de Déu, Scientific Director of the Fundacion Perez Scremini in Montevideo, Uruguay, and the Hospital Austral in Buenos Aires, Argentina
Haimanot Kasahun (Ethiopia) – Yvonne Award 2024 recipient, Clinical oncologist and Assistant Professor of Oncology at Saint Pauls Hospital Millennium Medical College, Chair of the Medical Oncology Special Interest Group at the African Organization for Research and Training in Cancer (AORTIC)
Ilya Tsimafeyeu (Russia) – Director, Bureau for Cancer Research, ASCO Central and Eastern Europe Regional Council Member
Isabel Mestres (Switzerland) – CEO of the City Cancer Challenge (C/Can)
Jasmine Kamboj (USA) – Community Oncologist and Hematologist at Mayo Clinic, Co-Lead of the ASCO Policy Communities of Practice, Minnesota Society of Clinical Oncology Board Member, OncoDaily Host and Editor of “Empowering Oncologists” Podcast
Jean-Yves Blay (France) – Professor of Medicine at the University Claude Bernard in Lyon, General Director of the Centre Leon Berard, the Comprehensive Cancer Centre of Lyon, President of the French Federation of Cancer Centers Unicancer
Jeffrey Dome (USA) – Senior Vice President of Cancer and Blood Disorders Center and Chief of the Division of Oncology at Children’s National Hospital, President of SIOP North America
Jemma Arakelyan (Hong Kong, China) – Medical Oncologist, CEO at the Institute of Cancer and Crisis
Joseph Grossman (USA) – Vice President of Early Clinical Development, Agenus
Joshua Brody (USA) – Associate Professor, Division of Hematology and Oncology at Icahn School of Medicine, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, Mount Sinai
Julie Torode (UK) – Director of Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy at King’s College London
Justin Stebbing (UK) – Editor-in-Chief of Oncogene, Visiting Professor of Cancer Medicine and Oncology, Imperial College of London, Professor of Biomedical Sciences, ARU, Cambridge
Katherine Van Loon (USA) – Director of the Global Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center, Editor-in-Chief of JCO Global Oncology (JCO GO)
Kathleen M. Schmeler (USA) – Professor in the Department of Gynecologic Oncology and Reproductive Medicine, Associate Vice President of Global Oncology, Division of Cancer Network, The University of Texas MD Anderson Cancer Center
Lacy Hubbard (USA) – President and Chief Executive Officer of Elekta Foundation
Liana Safaryan (Armenia) – Chief of the Department of Oncology, Yeolyan Hematology and Oncology Center
Lidia Schapira (USA) – Co-Editor-in-Chief of the CancerWorld Magazine, Professor of Medicine, Stanford University School of Medicine, Director of the Cancer Survivorship Program, Faculty Co-Director for Clinical Research and Clinical Trials, Office of Cancer Health Equity at Stanford Cancer Institute, Associate Editor of the Journal of Clinical Oncology
Lilit Harutyunyan (Armenia) – Head of Oncology Clinic at Mikaelyan Institute of Surgery, Chairperson of the Department of Oncology at Yerevan State Medical University
Lorelei Mucci (USA) – Head of the Cancer Epidemiology and Cancer Prevention Program, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Director of Strategic Research Partnerships at the American Cancer Society
Maite Bourlon (Mexico) – Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Director of the Genitourinary Cancers Program at Universidad Nacional Autónoma de México, Chair of the ASCO IDEA Steering Group
Margaret Gatti-Mays (USA) – Section chief of Breast Medical Oncology at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Associate professor of Medical Oncology at The Ohio State University College of Medicine
Maria Babak (Hong Kong, China) – Assistant Professor of Department of Chemistry, City University of Hong Kong, Board Member of the Institute of Cancer and Crisis
Maryam Lustberg (USA) – Immediate Past-President of the Multinational Association of Supportive Care in Cancer (MASCC), Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, Chief of Breast Medical Oncology, Associate Professor of Internal Medicine (Medical Oncology) at Yale
Matti Aapro (Switzerland) – President of Sharing Progress in Cancer Care (SPCC), President of All.Can, Past-President of European Cancer Organization (ECO), Chair of the Editorial Board of OncoDaily Medical Journal, Board Member of UICC
Nagashree Seetharamu (USA) – Professor at Zucker School of Medicine at Hofstra/Northwell, Director of Thoracic and Head/Neck Malignancies at Northwell Health
Naval Daver (USA) – Professor and Director of the Leukemia Research Alliance Program, Department of Leukemia, MD Anderson Cancer Center
Nazik Hammad (Canada) – Professor in the Division of Hematology-Oncology at St. Michael’s Hospital, University of Toronto, Chair of the Education and Training Committee of the African Organization in Research and Training in Cancer (AORTIC), Executive Member of the Global Oncology Program at Queen’s University
Olubukola Ayodele (UK) – Consultant Medical Oncologist and Breast Cancer Tumour Lead, University Hospitals of Leicester NHS Trust, Honorary Senior Lecturer, Leicester Cancer Research Centre, University of Leicester
Onyinye Balogun (USA) – Assistant Professor of Radiation Oncology at Weill Cornell Medicine, Co-Founder/CMO Mission-Driven Tech
Petros Grivas (USA) – Professor and Clinical Director of Genitourinary Cancers Program at University of Washington, Department of Medicine, Division of Hematology Oncology, and at Clinical Research Division, Fred Hutch Cancer Center
Philip Kantoff (USA) – CEO and Co-Founder, Convergent Therapeutics, Past Chairman of Medicine at Memorial Sloan Kettering Cancer Center, Jerome and Nancy Kohlberg Emeritus Chair in Medicine at Harvard Medical School
Pietro Presti (Italy) – Chief Executive Officer at Sharing Progress In Cancer Care (SPCC)
Piotr Wysocki (Poland) – Professor and the Head of the Clinical Oncology Department at Jagiellonian University-Medical College, Past-President of the Polish Society of Clinical Oncology, Chair of the ASCO European Regional Council
Pramesh CS (India) – Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Board Member of Union for International Cancer Control (UICC), Convener for the National Cancer Grid of India
Raya Saab (USA) – Professor and Section Chief of Oncology, Lucile Packard Children’s Hospital, Stanford University, Director of the Bass Center Tissue Biorepository
Rob Pieters (Netherlands) – President-Elect of the International Society of Pediatric Oncology (SIOP), Chief Máxima International at the Princess Máxima Center
Roselle De Guzman (Philippines) – Medical Oncologist and Associate Professor at the Manila Central University-FDT Medical Foundation Hospital
Rossella Blasi (Italy) – Executive Director at European School of Oncology
Samvel Danelyan (Armenia) – Honorary President of the Armenian Association of Hematology and Oncology Former Director of the Yeolyan Hematology and Oncology Center, Senior Adviser at the Immune Oncology Research Institute
Sendurai Mani (USA) – Professor of Medicine and Chair for Translational Oncology at Brown University Warren Alpert Medical School, Associate director for Translational Oncology at the Legorreta Cancer Center
Shikha Jain (USA) – Associate Professor of Medicine, Division of Hematology and Oncology, Director of Communication Strategies in Medicine at the University of Illinois Chicago, GI Oncology Integrated Practice Unit (IPU) Lead, Founder and Board Chair Women in Medicine, Founder & Chair Women in Medicine Summit, Co-Founder of IMPACT
Sujuan Ba (USA) – President and CEO at National Foundation for Cancer Research and the Asian Fund for Cancer Research, Co-founder of the Global Coalition for Adaptive Research and the AIM-HI Accelerator Fund
Susanna Greer (USA) – Chief Scientific Officer of the V Foundation for Cancer Research
Susannah Stanway (UK) – Honorary Consultant Medical Oncology at Royal Marsden NHS Foundation Trust, Senior teaching fellow at Institute of Cancer Research, Co-convenor of London Global Cancer Week
Tezer Kutluk (Turkey) – Past-President of UICC, Professor of Pediatrics and Pediatric Oncology, Chairman of the Scientific Committee at Medicana Health International
Uta Schmidt-Straßburger (Germany) – Scientific Director of Advanced Oncology study program, Ulm University
Vania Wisdom (UK) – Senior Executive Editor and Oncology Ambassador at The Lancet
Verna Vanderpuye (Ghana) – Professor and Senior Consultant, National Center for Radiotherapy, Oncology and Nuclear Medicine, Korlebu Teaching Hospital, Accra, Co-chair of the Lancet Commission on Women and Cancer
Vivek Subbiah (USA) – Yvonne Award 2024 Recipient, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute
Wade Swenson (USA) –Medical Director at Lakewood Health System in Staples, Minnesota, Clinical Associate Professor at the University of North Dakota School of Medicine, President-Elect of the Minnesota Chapter of the American College of Healthcare Executives, Presidential Leadership Scholar and a National Rural Health Association Rural Health Fellow, founder of the Rural Cancer Institute
Wafik El-Deiry (USA) – Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University
Yan Liu (China) – Chief Medical Officer at Yantai Dongcheng Pharmaceutical Group, Past-Chair of the translational research, radiotherapy and imaging at EORTC
Yüksel Ürün (Turkey) – Professor of Medical Oncology, Ankara University School of Medicine, Founder of the Turkish Oncology Group Kidney Cancer Consortium (TKCC)